Clinical Laserthermia Systems AB (CLS B) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Q-linea AB

Corline Biomedical AB

Promimic AB

Enzymatica AB

Clinical Laserthermia Systems AB

OssDsign AB

Boule Diagnostics AB

Integrum AB

Episurf Medical AB

Curasight A/S

Lumito AB

Why is Clinical Laserthermia Systems AB ?

Flat results in Mar 26

NET SALES(HY) At SEK 2.11 MM has Grown at -76.88%
INTEREST(HY) At SEK 0.09 MM has Grown at 347.62%
INVENTORY TURNOVER RATIO(HY) Lowest at 4.52 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 22.80%, its profits have risen by 12.1%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Clinical Laserthermia Systems AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Clinical Laserthermia Systems AB

-100.0%

-0.33

126.20%

OMX Stockholm 30

28.68%

1.89

15.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

66.42%

EBIT Growth (5y)

7.33%

EBIT to Interest (avg)

-28.36

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.38

Sales to Capital Employed (avg)

0.27

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.49

EV to EBIT

-5.23

EV to EBITDA

-5.75

EV to Capital Employed

3.15

EV to Sales

8.68

PEG Ratio

Dividend Yield

ROCE (Latest)

-60.25%

ROE (Latest)

-60.35%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK -31.2 MM

ROCE(HY)

Highest at -50.2%

PRE-TAX PROFIT(Q)

At SEK -7.37 MM has Grown at 51.64%

NET PROFIT(Q)

At SEK -7.37 MM has Grown at 51.63%

EPS(Q)

Highest at SEK -0.24

-16What is not working for the Company

NET SALES(HY)

At SEK 2.11 MM has Grown at -76.88%

INTEREST(HY)

At SEK 0.09 MM has Grown at 347.62%

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.52 times

RAW MATERIAL COST(Y)

Grown by 320.32% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -21.44 %

Here's what is working for Clinical Laserthermia Systems AB

Operating Cash Flow

Highest at SEK -31.2 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Pre-Tax Profit

At SEK -7.37 MM has Grown at 51.64%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit

At SEK -7.37 MM has Grown at 51.63%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS

Highest at SEK -0.24

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Here's what is not working for Clinical Laserthermia Systems AB

Net Sales

At SEK 2.11 MM has Grown at -76.88%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (SEK MM)

Interest

At SEK 0.09 MM has Grown at 347.62%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Inventory Turnover Ratio

Lowest at 4.52 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debt-Equity Ratio

Highest at -21.44 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 320.32% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales